KELOWNA, BC – October 11, 2016 – Laguna Blends (CSE:LAG; OTCMKTS:LAGBF; FRA:LB6A), is pleased to announce that it has signed a letter of intent (the “LOI”) with Carlsbad Naturals (“Carlsbad”) whereby Laguna and Carlsbad plan to enter into an equity acquisition and exclusive licence agreement (“Equity and License Agreement”) for the purpose of pursuing mutually beneficial business opportunities in the Cannabidiol (CBD) bottled water Industry and CBD ingestible products Industry (the “Proposed Transaction”).
Carlsbad is a market leader in the distribution and sales of nano-amplified CBD bottled water in the USA. The Company has a proprietary process of incorporating CBD into its formulation. Carlsbad Naturals has achieved unaudited U.S. sales in excess of $500,000 in its first year of business as of August 31, 2016.
The hemp cannabinoid innovator, Isodiol, sources nano-amplified hemp CBD to manufacturers to create unique finished products. Isodiol is a shareholder in Carlsbad.
“We are proud to announce the alignment of Laguna Blends and Carlsbad Naturals,” states Jared Berry, co-Founder of Carlsbad Naturals. “Laguna Blends’ extensive client base and distribution network will fulfill the growing demand for hemp CBD products worldwide.”
Mr. Stuart Gray, Laguna’s CEO said “With the growing awareness and market demand of CBD worldwide Laguna is positioning itself to be a market leader in the sale of CBD bottled water. In addition to the current sales growth of Carlsbad, Laguna can generate CBD water sales through its existing affiliates in the USA and Canada. Laguna currently is in discussions internationally with wholesale distributors regarding Carlsbad white label opportunities.”
Mr. Ray Grimm, Laguna’s President stated, “The partnership with Carlsbad, firmly solidifies Laguna as a unique player in the crowded multibillion dollar bottled water industry. The team of Doctors that formulated the Carlsbad water did so with the sole purpose of creating a high alkaline water offering the benefits of CBD. Many believe this to be the next evolution in the water industry, providing unique health benefits due to the proprietary nanotechnology. Carlsbad CBD water provides antioxidants at the cellular level along with providing cellular hydration and energy.”
Connect with Laguna Blends (CSE:LAG; OTCMKTS:LAGBF; FRA:LB6A) to receive an Investor Presentation.
Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) will release its financial results for the third quarter fiscal 2021 ended December 31, 2020 before financial markets open on February 9, 2021.
Aurora Cannabis Closes Previously Announced Bought Deal Financing Over-Allotment Option Exercised in Full
NYSE | TSX: ACB
Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000 . The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.
Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000. The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.
Each Unit is comprised of one common share of the Company (a “Common Share”) and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”). Each Warrant is exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering at an exercise price of US$12.60 per Warrant Share, subject to adjustment in certain events.
/R E P E A T — AMP German Cannabis Group and Aphria’s subsidiary CC Pharma GmbH enter into Strategic Co-Promotion Agreement for the Sale of Medical Cannabis in Germany/
AMP German Cannabis Group Inc. (” AMP “) (CSE: XCX ), ( Frankfurt : C4T ) (ISIN: CA00176G1028) and Aphria Inc.’s (” Aphria “) (TSX: APHA ) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH (” CC Pharma “), have entered into a strategic agreement (the ” Co-Promotion Agreement “) covering joint marketing of sales for Aphria brand medical cannabis products for the German market.
The Co-Promotion Agreement is a collaboration contract between AMP and CC Pharma to sell the Aphria medical cannabis brand in Germany . In addition, AMP will organize with the support of CC Pharma, “information events” in Germany to market Aphria branded products to doctors and pharmacists.
HempFusion Wellness Inc. ( TSX:CBD.U ) ( FWB:8OO ) (“ HempFusion ” or the “ Company ”) is pleased to announce that it has been included in two leading cannabis & hemp-derived CBD focused exchange-traded funds (“ ETFs ”), AdvisorShares Pure US Cannabis ETF ( NYSE:MSOS ) and AdvisorShares Pure Cannabis ETF ( NYSE:YOLO ).
AdvisorShares is a leading sponsor of actively managed ETFs. Pure US Cannabis ETF (MSOS) is the only US-listed ETF dedicated solely to US cannabis exposure, with over US$616,000,000 in assets under management (“ AUM ”). Pure Cannabis ETF (YOLO) was the first US-based actively managed ETF focused on the global cannabis industry. YOLO and MSOS endeavor to achieve long-term capital growth by investing in some of the largest foreign and domestic cannabis and hemp-derived CBD companies. The two AdvisorShares ETFs have a combined AUM of over US$880,000,000 as of January 22, 2021.